Macromolecule uptake in human melanoma xenografts: relationships to blood supply, vascular density, microvessel permeability and extracellular volumefraction
Ba. Graff et al., Macromolecule uptake in human melanoma xenografts: relationships to blood supply, vascular density, microvessel permeability and extracellular volumefraction, EUR J CANC, 36(11), 2000, pp. 1433-1440
The uptake of albumin-Evans blue in human melanoma xenografts was studied a
nd related to blood supply, vascular density, microvessel permeability and
extracellular volume fraction in an attempt to identify transport barriers
limiting the delivery of macromolecular therapeutic agents to tumours. Thre
e melanoma lines (A-07, R-18, U-25) were included in the study. Tissue conc
entrations of albumin-Evans blue were determined by spectrophotometry. The
[Rb-86] uptake method was used to measure tumour blood supply. Vascular den
sity was determined by stereological analysis of histological sections. Mic
rovessel permeability was measured by using the indicator diffusion method.
Contrast-enhanced magnetic resonance imaging was used to measure tumour ex
tracellular volume fraction. The fractional volume of the extracellular spa
ce governed the uptake of albumin-Evans blue in the tumours. The uptake of
albumin-Evans blue in the extracellular space was primarily limited by tran
sport in the vasculature and not by transport across the microvascular wall
or the transport through the interstitium. Our study thus suggests that no
vel strategies for improving the delivery of macromolecular therapeutic age
nts to tumours should focus on enhancing the tumour blood supply, increasin
g the half-life of the therapeutic agent in the blood plasma and/or enhanci
ng the volume of the extracellular space available to macromolecules rather
than on increasing the permeability of the microvascular wall or improving
diffusion conditions in the tumour interstitium. (C) 2000 Elsevier Science
Ltd. All rights reserved.